导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -19.89% | 989/1050 |
| 近一周 | -2.31% | 537/1104 |
| 近一月 | -3.78% | 458/1102 |
| 近一季 | -8.82% | 616/1092 |
| 近半年 | -17.45% | 941/1070 |
| 近一年 | -15.87% | 830/1018 |
| 近两年 | 5.82% | 862/926 |
| 近三年 | -7.25% | 722/834 |
| 成立以来 | 155.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.54% 964/1070 |
-10.63% 926/1101 |
- - |
- - |
| 2025 | 14.67% 760/1065 |
-2.92% 949/1014 |
1.97% 510/1038 |
11.83% 814/1050 |
3.58% 215/1065 |
| 2024 | 14.85% 179/1011 |
7.00% 59/960 |
-2.01% 443/983 |
14.88% 238/991 |
-4.65% 645/1011 |
| 2023 | -23.55% 751/952 |
0.11% 625/880 |
-10.69% 787/895 |
-3.38% 225/915 |
-11.50% 891/952 |
| 2022 | 1.91% 12/867 |
-3.97% 22/773 |
6.90% 415/806 |
-3.76% 46/845 |
3.15% 274/867 |
| 2021 | 24.55% 119/740 |
6.02% 40/580 |
-1.46% 557/659 |
8.92% 79/704 |
9.47% 93/740 |
| 2020 | 38.42% 308/554 |
-7.92% 355/419 |
11.82% 386/466 |
21.20% 45/517 |
10.93% 338/554 |
| 2019 | 47.43% 170/410 |
24.65% 724/1146 |
3.18% 105/1228 |
6.00% 182/390 |
8.13% 233/410 |
| 2018 | -17.62% 46/349 |
- - |
-5.96% 211/990 |
-4.28% 426/1000 |
-5.87% 77/1080 |
| 2017 | 22.60% 75/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实物流产业股票A VS. 东吴新产业精选股票A(580008) |